Risultati della ricerca - Editta Baldini

  • Mostra 1 - 8 risultati su 8
Raffina i risultati
  1. 1
    Mutational Analysis in Cytological Specimens of Advanced Lung Adenocarcinoma: A Sensitive Method for Molecular Diagnosis

    Mutational Analysis in Cytological Specimens of Advanced Lung Adenocarcinoma: A Sensitive Method for Molecular Diagnosis di Laura Boldrini, Silvia Gisfredi, Silvia Ursino, Tiziano Camacci, Editta Baldini, Franca Melfi, Gabriella Fontanini

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

    ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin di Marcello Tiseo, Paola Bordi, Beatrice Bortesi, Luca Boni, C. Boni, Editta Baldini, Francesco Grossi, F. Recchia, Francesca Zanelli, Gabriella Fontanini, Nadia Naldi, Nicoletta Campanini, Cinzia Azzoni, Cesare Bordi, Andrea Ardizzoni

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Platinum-Etoposide Chemotherapy in Elderly Patients With Small-Cell Lung Cancer: Results of a Randomized Multicenter Phase II Study Assessing Attenuated-Dose or Full-Dose With Lenograstim Prophylaxis—A Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) Study

    Platinum-Etoposide Chemotherapy in Elderly Patients With Small-Cell Lung Cancer: Results of a Randomized Multicenter Phase II Study Assessing Attenuated-Dose or Full-Dose With Leno... di Andrea Ardizzoni, Adolfo Favaretto, Luca Boni, Editta Baldini, Federico Castiglioni, Paola Antonelli, Franca Pari, Carmelo Tibaldi, A Altieri, S. Barbera, Giancarlo Cacciani, M Raimondi, Lucia Tixi, Micaela Stefani, S. Monfardini, A Antilli, Riccardo Rosso, Adriano Paccagnella

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

    IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lun... di Fabrice Barlési, Makoto Nishio, Manuel Cobo, N. Steele, V.V. Paramonov, B. Parente, Rachel Dear, H. Bérard, Nir Peled, Lasika Seneviratne, Editta Baldini, Satoshi Watanabe, Keiko Goto, Diana Mendus, Hina Patel, Yu Deng, Marcin Kowanetz, Tien Hoang, Wei‐Hung Lin, Vassiliki A. Papadimitrakopoulou

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

    Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients di Marina Chiara Garassino, Alain Gelibter, Francesco Grossi, Rita Chiari, Héctor Soto Parrà, Stefano Cascinu, Francesco Cognetti, D. Turci, Livio Blasi, Carmelo Bengala, Enrico Mini, Editta Baldini, Silvia Quadrini, Giovanni Luca Ceresoli, Paola Antonelli, Enrico Vasile, Carmine Pinto, Gianpiero Fasola, Domenico Galetta, Marianna Macerelli, Diana Giannarelli, Giuseppe Lo Russo, Filippo de Marinis

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

    Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, s... di Naiyer A. Rizvi, Julien Mazières, David Planchard, Thomas E. Stinchcombe, Grace K. Dy, Scott Antonia, Leora Horn, H. Léna, Elisa Minenza, B. Mennecier, Gregory A. Otterson, Luis T. Campos, David R. Gandara, Benjamin Levy, Suresh Nair, Gérard Zalcman, Jürgen Wolf, Pierre‐Jean Souquet, Editta Baldini, Federico Cappuzzo, C. Chouaïd, Afshin Dowlati, Rachel E. Sanborn, Ariel López-Chávez, Christian Grohé, Rudolf M. Huber, Christopher Harbison, Christine Baudelet, Brian Lestini, Suresh S. Ramalingam

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

    Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunot... di Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo, Céline Mascaux, Anne Madroszyk, Federico Cappuzzo, Werner Hilgers, Gianpiero Romano, Fabrice Denis, Santiago Viteri, D. Debieuvre, Domenico Galetta, Editta Baldini, M. Razaq, G. Robinet, Michele Maio, Angelo Delmonte, Benoît Roch, Patrick Masson, Wolfgang Schuette, Alona Zer, Jordi Remón, D Costantini, B. Vasseur, Rafał Dziadziuszko, Giuseppe Giaccone, Milada Zemanová, Benjamin Besse, Clément Bonnet, Jacques Cadranel, C. Chouaïd, Alexis B. Cortot, D. Debieuvre, B. Delclaux, Fabrice Denis, Boris Duchemann, Claude El Kouri, François‐Régis Ferrand, M. Ginoux, Werner Hilgers, Anne Madroszyk, Patrick Masson, Julien Mazières, O. Molinier, Denis Moro‐Sibilot, Éric Pichon, Céline Mascaux, G. Robinet, Benoît Roch, Gérard Zalcman, Gerlinde Schmidtke-Schrezenmeier, Wolfgang Schuette, László Urbán, Maya Gottfried, Hovav Nechushtan, Nir Peled, M. Wollner, Alona Zer, Editta Baldini, Laura Bonanno, Andrea Bonetti, Federico Cappuzzo, Angelo Delmonte, Domenico Galetta, Michele Maio, V. Minotti, Antonio Rea, Gianpiero Romano, Davide Tassinari, Giuseppe Tonini, Rafał Dziadziuszko, Bogusława Karaszewska, Aleksandra Szczésna, Manuel Cobo, Javier de Castro, Enriqueta Felip, M.R. García Campelo, Ainhoa Hernández, Teresa Morán, Mariano Provencio, Santiago Viteri, Abhijit Dasgupta, Nashat Gabrail, Giuseppe Giaccone, A. Harshad, Stephen V. Liu, D. Oubre, Rajiv Panikkar, M. Razaq, Rachel E. Sanborn

    Pubblicazione 2023
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation

    Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer:... di Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro, Daniele Rossini, Vincenzo Formica, Mario Scartozzi, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Nicoletta Pella, Francesca Bergamo, Alessandra Raimondi, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Cristina Granetto, Fable Zustovich, M. Ronzoni, Silvana Leo, Federica Morano, Fotios Loupakis, Federica Buggin, Vittorina Zagonel, Matteo Fassan, Chiara Cremolini, Luca Boni, Filippo Pietrantonio, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Giuseppe Aprile, Antonio Ardizzoia, C. Aschele, Editta Baldini, Alberto Ballestrero, Alessandro Bertolini, Roberto Bordonaro, Giorgia Boscolo, Angela Buonadonna, Saverio Cinieri, Matteo Clavarezza, Domenico Corsi, Enrico Cortesi, Filippo de Braud, Samantha Di Donato, Alfredo Falcone, Adolfo Favaretto, Vincenzo Formica, Giovanni Luca Frassineti, Antonio Frassoldati, M. Frisinghelli, Teresa Gamucci, Luca Gianni, Filippo Giovanardi, Stefania Gori, Roberta Grande, Cristina Granetto, Silvana Leo, Francesco Leone, Sara Lonardi, Andrea Luciani, Carlo Milandri, Nicoletta Pella, Andrea Sartore‐Bianchi, Mario Scartozzi, Nicola Silvestris, Emiliano Tamburini, Gianluca Tomasello, Giuseppe Tonini, Giampaolo Tortora, C. Vergani, Albrto Zaniboni, Fable Zustovich

    Pubblicazione 2023
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: